Screener
Perspective Therapeutics CATX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Perspective Therapeutics’s reported figures.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
FAQ
- What is Perspective Therapeutics's enterprise value?
- Perspective Therapeutics (CATX) reported enterprise value of $344.32M in Q2 2026.
- How has Perspective Therapeutics's enterprise value changed year-over-year?
- Perspective Therapeutics's enterprise value increased by 33.3% year-over-year, from $258.22M to $344.32M.
- What is the long-term trend for Perspective Therapeutics's enterprise value?
- Over 4 years (2020 to 2025), Perspective Therapeutics's enterprise value has grown at a 57.6% compound annual growth rate (CAGR), from $28.68M to $177M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Perspective Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude